封面
市場調查報告書
商品編碼
1612827

透明質酸皮膚填充劑的全球市場:產業分析,規模,佔有率,成長,趨勢,預測(2024年~2031年)

Hyaluronic Acid Based Dermal Fillers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日期: | 出版商: Persistence Market Research | 英文 192 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

2024年全球透明質酸真皮填充劑市場規模預估為48億美元,2024-2031年預測期間複合年增長率為7.8%,到2031年將達到81億美元。

基於透明質酸的真皮填充劑是非永久性注射療法,用於透過補充流失的透明質酸來減少皺紋、恢復體積和增強面部特徵。這些真皮填充劑在美容手術中廣泛流行,因為它們提供了一種微創解決方案,具有自然的外觀。由於對美容、抗衰老解決方案和臉部年輕化手術的需求不斷增加,這些填充劑的市場正在迅速擴大。此外,人們對美容治療的認識和接受度不斷提高正在推動全球市場的成長。

全球透明質酸真皮填充劑市場受到多種因素的推動,包括對非侵入性美容手術(尤其是臉部年輕化)日益增長的需求。世界老化人口的成長是一個主要推動因素,需要解決方案來減少明顯的老化跡象。此外,透明質酸填充劑技術的進步提供了更持久的效果並提高了安全性,有助於市場擴張。微創治療的日益普及,加上透明質酸填充劑的便利性和有效性,正在吸引更多的人接受這些手術。此外,針對不同皮膚類型推出不同配方的新產品正在創造新的市場機會。

由於新興市場對微創整容手術的需求不斷增長,該市場提供了巨大的成長機會。隨著亞太和拉丁美洲等地區可支配收入的增加,越來越多的人選擇整容手術,從而產生了對透明質酸真皮填充劑的需求。透明質酸交聯和生物刺激技術等先進技術的整合有望提高真皮填充劑的效果和安全性,從而吸引更大的客戶群。此外,與護膚品牌的合作以及加強消費者對透明質酸真皮填充劑益處的教育是市場參與者擴大影響力的關鍵機會。

本報告提供全球透明質酸皮膚填充劑市場相關調查,提供各產品類型,各用途,各最終用途,各地區趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍和定義
  • 市場動態
  • 宏觀經濟要素
  • COVID-19影響分析
  • 預測要素- 相關性及影響

第3章 附加價值的洞察

  • 產品類型的招聘分析
  • 法規情形
  • 價值鏈分析
  • 主要的交易合併
  • 大環境分析
  • 波特的五力分析

第4章 透明質酸皮膚填充劑市場預測:實際成果(2019年~2023年)及預測(2024年~2031年)

  • 主要的焦點
  • 市場規模(10億美元)分析與預測
  • 透明質酸皮膚填充劑市場預測:各產品類型
  • 透明質酸皮膚填充劑市場預測:各用途
  • 透明質酸皮膚填充劑市場預測:各最終用途

第5章 透明質酸皮膚填充劑市場預測:各地區

  • 主要的焦點
  • 過去的市場規模(10億美元)的分析,各地區,2019年~2023年
  • 目前市場規模(10億美元)的分析與預測,各地區,2024年~2031年
  • 市場魅力分析:各地區

第6章 北美的透明質酸皮膚填充劑市場預測:實際成果(2019年~2023年)及預測(2024年~2031年)

第7章 歐洲的透明質酸皮膚填充劑市場預測:過去(2019-2023)及預測(2024-2031)

第8章 東亞的透明質酸皮膚填充劑市場預測:實際成果(2019年~2023年)及預測(2024年~2031年)

第9章 南亞及大洋洲的透明質酸皮膚填充劑市場預測:實際成果(2019年~2023年)及預測(2024年~2031年)

第10章 南美的透明質酸皮膚填充劑市場預測:實際成果(2019年~2023年)及預測(2024年~2031年)

第11章 中東·非洲的透明質酸皮膚填充劑市場預測:實際成果(2019年~2023年)及預測(2024年~2031年)

第12章 競爭情形

  • 市場佔有率分析,2024年
  • 市場結構
  • 企業簡介(詳細內容- 概要,財務,策略,最近的趨勢)
    • Allergan Aesthetics (AbbVie Inc.)
    • Galderma
    • Anika Therapeutics Inc.
    • Merz Pharmaceuticals
    • Genzyme Corporation
    • Bio plus Co. Ltd.
    • LG Life Sciences
    • Sinclair Pharma
    • Sculpt Luxury
    • Dermal Fillers Ltd.
    • Bioxis Pharmaceutical
    • Sinclair Pharma; Laboratories
    • Bohus BioTech AB

第13章 附錄

簡介目錄
Product Code: PMRREP34953

Persistence Market Research has recently released a comprehensive report on the global market for Hyaluronic Acid Based Dermal Fillers. This report provides an in-depth analysis of the key market dynamics, including growth drivers, trends, opportunities, and challenges, offering valuable insights into the market structure. The publication also presents exclusive data and forecasts that outline the expected growth trajectory of the global Hyaluronic Acid Based Dermal Fillers Market from 2024 to 2031.

Key Insights:

  • Hyaluronic Acid Based Dermal Fillers Market Size (2024E): US$ 4.8 Bn
  • Projected Market Value (2031F): US$ 8.1 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7.8%

Hyaluronic Acid Based Dermal Fillers Market - Report Scope:

Hyaluronic acid-based dermal fillers are non-permanent injectable treatments used to reduce wrinkles, restore volume, and enhance facial features by replenishing lost hyaluronic acid. These dermal fillers are widely popular in aesthetic procedures, as they provide a minimally invasive solution with natural-looking results. The market for these fillers is rapidly expanding due to the rising demand for cosmetic enhancements, anti-aging solutions, and facial rejuvenation procedures. Additionally, growing awareness and acceptance of aesthetic treatments are fueling market growth globally.

Market Growth Drivers:

The global Hyaluronic Acid Based Dermal Fillers market is propelled by several factors, including the increasing desire for non-invasive cosmetic procedures, particularly for facial rejuvenation. The growing aging population worldwide is a key driver, as individuals seek solutions to reduce the visible signs of aging. Furthermore, the advancements in hyaluronic acid filler technology, which offer longer-lasting results and increased safety profiles, are contributing to market expansion. The rising popularity of minimally invasive treatments, combined with the convenience and effectiveness of hyaluronic acid-based fillers, is attracting more individuals to undergo these procedures. Additionally, the availability of new product variants with different formulations for various skin types is opening up new market opportunities.

Market Restraints:

Despite strong growth prospects, the market faces challenges related to the high cost of treatments and the potential side effects of dermal fillers, such as bruising, swelling, and allergic reactions. The need for skilled professionals to administer these treatments also limits accessibility in certain regions, especially in developing economies. Moreover, the lack of standardization in the hyaluronic acid filler market, along with concerns over counterfeit products, poses a challenge for industry growth. Regulatory hurdles and the potential for complications related to the use of dermal fillers may also hinder the market's expansion.

Market Opportunities:

The market presents significant growth opportunities driven by the increasing demand for minimally invasive cosmetic procedures in emerging markets. As disposable income rises in regions like Asia Pacific and Latin America, more individuals are opting for cosmetic enhancements, creating a demand for hyaluronic acid-based dermal fillers. The integration of advanced technologies such as hyaluronic acid crosslinking and bio-stimulation techniques is expected to enhance the results and safety of dermal fillers, thereby attracting a larger customer base. Furthermore, collaborations with skincare brands and expanding consumer education on the benefits of hyaluronic acid dermal fillers are key opportunities for market players to grow their presence.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Hyaluronic Acid Based Dermal Fillers market?
  • How are advancements in hyaluronic acid technology influencing the market dynamics?
  • Who are the major players in the market, and what strategies are they employing to maintain their competitive advantage?
  • What are the emerging trends in the global Hyaluronic Acid Based Dermal Fillers market, and what is the future outlook?
  • How are market players addressing challenges related to safety, regulation, and product quality?

Competitive Intelligence and Business Strategy:

Leading companies in the global Hyaluronic Acid Based Dermal Fillers market, including Allergan (AbbVie Inc.), Revance Therapeutics, Inc., Galderma S.A., Ipsen Pharma, and Medytox Inc., focus on product innovation and expanding their portfolios of hyaluronic acid-based fillers. These companies invest heavily in research and development to improve the safety, effectiveness, and longevity of their products. Additionally, strategic partnerships and collaborations with aesthetic clinics and professionals are helping them expand their market share. Brand awareness campaigns, customer education programs, and the launch of new product variants targeting different age groups and skin types are also key strategies employed by leading players.

Key Companies Profiled:

  • Allergan Aesthetics (AbbVie Inc.)
  • Galderma
  • Anika Therapeutics Inc.
  • Merz Pharmaceuticals
  • Genzyme Corporation
  • Bio plus Co. Ltd.
  • LG Life Sciences
  • Sinclair Pharma
  • Sculpt Luxury
  • Dermal Fillers Ltd.
  • Bioxis Pharmaceutical
  • Sinclair Pharma; Laboratories
  • Bohus BioTech AB

Market Segmentation

By Product Type

  • Single Phase Products
  • Duplex Products

By Application

  • Wrinkle Removal
  • Lip Augmentation
  • Rhinoplasty
  • Others

By End User

  • Specialty and Dermatology Clinics
  • Hospitals and Clinics
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Hyaluronic Acid Based Dermal Fillers Market Snapshot, 2024 - 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Type Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
    • 3.3.1. List of Distribution Channel/Marketplaces
      • 3.3.1.1. Retail
      • 3.3.1.2. Audiology
      • 3.3.1.3. E-Commerce
    • 3.3.2. List of End User (Industry)
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
  • 4.3. Hyaluronic Acid Based Dermal Fillers Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2023
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
      • 4.3.3.1. Single Phase Products
      • 4.3.3.2. Duplex Products
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Hyaluronic Acid Based Dermal Fillers Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
      • 4.4.3.1. Wrinkle Removal
      • 4.4.3.2. Lip Augmentation
      • 4.4.3.3. Rhinoplasty
      • 4.4.3.4. Others
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Hyaluronic Acid Based Dermal Fillers Market Outlook: End-use
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019 - 2023
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
      • 4.5.3.1. Specialty & Dermatology Clinics
      • 4.5.3.2. Hospitals & Clinics
      • 4.5.3.3. Others
    • 4.5.4. Market Attractiveness Analysis: End-use

5. Hyaluronic Acid Based Dermal Fillers Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Application
    • 6.2.4. By End-use
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 6.4.1. Single Phase Products
    • 6.4.2. Duplex Products
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 6.5.1. Wrinkle Removal
    • 6.5.2. Lip Augmentation
    • 6.5.3. Rhinoplasty
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 6.6.1. Specialty & Dermatology Clinics
    • 6.6.2. Hospitals & Clinics
    • 6.6.3. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Application
    • 7.2.4. By End-use
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 7.4.1. Single Phase Products
    • 7.4.2. Duplex Products
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 7.5.1. Wrinkle Removal
    • 7.5.2. Lip Augmentation
    • 7.5.3. Rhinoplasty
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 7.6.1. Specialty & Dermatology Clinics
    • 7.6.2. Hospitals & Clinics
    • 7.6.3. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Application
    • 8.2.4. By End-use
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 8.4.1. Single Phase Products
    • 8.4.2. Duplex Products
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 8.5.1. Wrinkle Removal
    • 8.5.2. Lip Augmentation
    • 8.5.3. Rhinoplasty
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 8.6.1. Specialty & Dermatology Clinics
    • 8.6.2. Hospitals & Clinics
    • 8.6.3. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Application
    • 9.2.4. By End-use
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 9.4.1. Single Phase Products
    • 9.4.2. Duplex Products
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 9.5.1. Wrinkle Removal
    • 9.5.2. Lip Augmentation
    • 9.5.3. Rhinoplasty
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 9.6.1. Specialty & Dermatology Clinics
    • 9.6.2. Hospitals & Clinics
    • 9.6.3. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Application
    • 10.2.4. BY End-use
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 10.4.1. Single Phase Products
    • 10.4.2. Duplex Products
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 10.5.1. Wrinkle Removal
    • 10.5.2. Lip Augmentation
    • 10.5.3. Rhinoplasty
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 10.6.1. Specialty & Dermatology Clinics
    • 10.6.2. Hospitals & Clinics
    • 10.6.3. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Application
    • 11.2.4. By End-use
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 11.4.1. Single Phase Products
    • 11.4.2. Duplex Products
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 11.5.1. Wrinkle Removal
    • 11.5.2. Lip Augmentation
    • 11.5.3. Rhinoplasty
    • 11.5.4. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 11.6.1. Specialty & Dermatology Clinics
    • 11.6.2. Hospitals & Clinics
    • 11.6.3. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Allergan Aesthetics (AbbVie Inc.)
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Galderma
    • 12.3.3. Anika Therapeutics Inc.
    • 12.3.4. Merz Pharmaceuticals
    • 12.3.5. Genzyme Corporation
    • 12.3.6. Bio plus Co. Ltd.
    • 12.3.7. LG Life Sciences
    • 12.3.8. Sinclair Pharma
    • 12.3.9. Sculpt Luxury
    • 12.3.10. Dermal Fillers Ltd.
    • 12.3.11. Bioxis Pharmaceutical
    • 12.3.12. Sinclair Pharma; Laboratories
    • 12.3.13. Bohus BioTech AB

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations